PASITHEA THERAPEUTICS CORP. Basic Shares Outstanding (Weighted Average)
PASITHEA THERAPEUTICS CORP. (KTTA) reported Basic Shares Outstanding (Weighted Average) of 32.10 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfSharesOutstandingBasic · last filed 2026-08-14
- PASITHEA THERAPEUTICS CORP. weighted average number of shares outstanding, basic for the quarter ending 2026-06-30 was 32.10M shares, a 469.02% increase year-over-year.
- PASITHEA THERAPEUTICS CORP. weighted average number of shares outstanding, basic for the quarter ending 2026-03-31 was 24.34M shares, a 1000.66% increase year-over-year.
- PASITHEA THERAPEUTICS CORP. weighted average number of shares outstanding, basic for the quarter ending 2025-12-31 was 12.77M shares, a 918.08% increase year-over-year.
- PASITHEA THERAPEUTICS CORP. weighted average number of shares outstanding, basic for the quarter ending 2025-09-30 was 7.44M shares, a 612.89% increase year-over-year.
- PASITHEA THERAPEUTICS CORP. weighted average number of shares outstanding, basic for fiscal 2025 was 7.03M shares, a 541.47% increase from fiscal 2024.
- PASITHEA THERAPEUTICS CORP. weighted average number of shares outstanding, basic for fiscal 2024 was 1.10M shares, a 10.64% decline from fiscal 2023.
- PASITHEA THERAPEUTICS CORP. weighted average number of shares outstanding, basic for fiscal 2023 was 1.23M shares, a 2.83% decline from fiscal 2022.
- PASITHEA THERAPEUTICS CORP. weighted average number of shares outstanding, basic for fiscal 2022 was 1.26M shares, a 87.87% decline from fiscal 2021.
| Period end | Weighted Average Number of Shares Outstanding, Basic 3 month | Weighted Average Number of Shares Outstanding, Basic 3 month as first filed | Weighted Average Number of Shares Outstanding, Basic 6 month | Weighted Average Number of Shares Outstanding, Basic 6 month as first filed | Weighted Average Number of Shares Outstanding, Basic 8 month | Weighted Average Number of Shares Outstanding, Basic 9 month | Weighted Average Number of Shares Outstanding, Basic 9 month as first filed | Weighted Average Number of Shares Outstanding, Basic 12 month | Weighted Average Number of Shares Outstanding, Basic 12 month as first filed |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | 32.10M shares 10-Q · filed 2026-08-14 | 28.24M shares 10-Q · filed 2026-08-14 | 23.07M shares derived: average of 3 quarters · filed 2026-08-14 | 19.16M shares derived: average of 4 quarters · filed 2026-08-14 | |||||
| 2026-03-31 | 24.34M shares 10-Q · filed 2026-05-15 | 18.55M shares derived: average of 2 quarters · filed 2026-05-15 | 14.85M shares derived: average of 3 quarters · filed 2026-05-15 | 12.55M shares derived: average of 4 quarters · filed 2026-08-14 | |||||
| 2025-12-31 | 12.77M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | 10.11M shares derived: average of 2 quarters · filed 2026-03-30 | 8.62M shares derived: average of 3 quarters · filed 2026-08-14 | 7.03M shares 10-K · filed 2026-03-30 | |||||
| 2025-09-30 | 7.44M shares 10-Q · filed 2025-11-13 | 6.54M shares derived: average of 2 quarters · filed 2026-08-14 | 5.12M shares 10-Q · filed 2025-11-13 | 4.14M shares derived: average of 4 quarters · filed 2026-08-14 | |||||
| 2025-06-30 | 5.64M shares 10-Q · filed 2026-08-14 | 3.94M shares 10-Q · filed 2026-08-14 | 3.04M shares derived: average of 3 quarters · filed 2026-08-14 | 2.54M shares derived: average of 4 quarters · filed 2026-08-14 | |||||
| 2025-03-31 | 2.21M shares 10-Q · filed 2026-05-15 | 1.73M shares derived: average of 2 quarters · filed 2026-05-15 | 1.50M shares derived: average of 3 quarters · filed 2026-05-15 | 1.39M shares derived: average of 4 quarters · filed 2026-05-15 | |||||
| 2024-12-31 | 1.25M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | 1.15M shares derived: average of 2 quarters · filed 2026-03-30 | 1.11M shares derived: average of 3 quarters · filed 2026-03-30 | 1.10M shares 10-K · filed 2026-03-30 | |||||
| 2024-09-30 | 1.04M shares 10-Q · filed 2025-11-13 | 1.04M shares derived: average of 2 quarters · filed 2025-11-13 | 1.04M shares 10-Q · filed 2025-11-13 | 1.04M shares derived: average of 4 quarters · filed 2025-11-13 | |||||
| 2024-06-30 | 1.04M shares 10-Q · filed 2025-08-14 | 1.04M shares 10-Q · filed 2025-08-14 | 1.04M shares derived: average of 3 quarters · filed 2025-08-14 | 1.10M shares derived: average of 4 quarters · filed 2025-08-14 | |||||
| 2024-03-31 | 1.04M shares 10-Q · filed 2025-05-15 | 1.04M shares derived: average of 2 quarters · filed 2025-05-15 | 1.11M shares derived: average of 3 quarters · filed 2025-05-15 | 1.16M shares derived: average of 4 quarters · filed 2025-05-15 | |||||
| 2023-12-31 | 1.04M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-24 | 1.15M shares derived: average of 2 quarters · filed 2025-03-24 | 1.20M shares derived: average of 3 quarters · filed 2025-03-24 | 1.23M shares 10-K · filed 2025-03-24 | |||||
| 2023-09-30 | 1.26M shares 10-Q · filed 2024-11-13 | 25.16M shares 10-Q · filed 2023-11-13 | 1.28M shares derived: average of 2 quarters · filed 2024-11-13 | 1.29M shares 10-Q · filed 2024-11-13 | 25.78M shares 10-Q · filed 2023-11-13 | -16.08M shares derived: average of 4 quarters · filed 2024-11-13 | |||
| 2023-06-30 | 1.31M shares 10-Q · filed 2024-08-13 | 26.13M shares 10-Q · filed 2023-08-11 | 1.31M shares 10-Q · filed 2024-08-13 | 26.10M shares 10-Q · filed 2023-08-11 | -21.86M shares derived: average of 3 quarters · filed 2024-08-13 | -9.76M shares derived: average of 4 quarters · filed 2024-08-13 | |||
| 2023-03-31 | 1.30M shares 10-Q · filed 2024-05-14 | 26.07M shares 10-Q · filed 2023-05-12 | -33.45M shares derived: average of 2 quarters · filed 2024-05-14 | -13.45M shares derived: average of 3 quarters · filed 2024-05-14 | -4.23M shares derived: average of 4 quarters · filed 2024-05-14 | ||||
| 2022-12-31 | -68.20M shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-29 | -20.82M shares derived: average of 2 quarters · filed 2024-03-29 | -6.07M shares derived: average of 3 quarters · filed 2024-03-29 | 1.26M shares 10-K · filed 2024-03-29 | 25.25M shares 10-K · filed 2023-03-30 | ||||
| 2022-09-30 | 26.55M shares 10-Q · filed 2023-11-13 | 25.00M shares derived: average of 2 quarters · filed 2023-11-13 | 24.42M shares 10-Q · filed 2023-11-13 | 22.32M shares derived: average of 4 quarters · filed 2023-11-13 | |||||
| 2022-06-30 | 23.44M shares 10-Q · filed 2023-08-11 | 23.23M shares 10-Q · filed 2023-08-11 | 20.91M shares derived: average of 3 quarters · filed 2023-08-11 | 17.93M shares derived: average of 4 quarters · filed 2023-08-11 | |||||
| 2022-03-31 | 23.01M shares 10-Q · filed 2023-05-12 | 19.65M shares derived: average of 2 quarters · filed 2023-05-12 | 16.09M shares derived: average of 3 quarters · filed 2023-05-12 | 14.13M shares derived: average of 4 quarters · filed 2023-05-12 | |||||
| 2021-12-31 | 16.29M shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | 12.62M shares derived: average of 2 quarters · filed 2023-03-30 | 11.17M shares derived: average of 3 quarters · filed 2023-03-30 | 10.40M shares 10-K · filed 2023-03-30 | |||||
| 2021-09-30 | 8.96M shares 10-Q · filed 2022-11-14 | 8.61M shares derived: average of 2 quarters · filed 2022-11-14 | 8.44M shares 10-Q · filed 2022-11-14 | ||||||
| 2021-06-30 | 8.26M shares 10-Q · filed 2022-08-15 | 8.04M shares 10-Q · filed 2022-08-15 | |||||||
| 2021-03-31 | 7.95M shares 10-Q · filed 2022-05-16 | ||||||||
| 2020-12-31 | 7.36M shares 10-K · filed 2022-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Rocket One Inc. (RKTO) | United States | $0.019B |